The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines: Clinical pathway for anxiety and depression in cancer
Abstract
PURPOSE: A clinical pathway for anxiety and depression in adult cancer patients was developed to guide best practice in Australia. METHODS: The pathway was based on a rapid review of existing guidelines, systematic reviews and meta-analyses, stakeholder interviews, a Delphi process with 87 multidisciplinary stakeholders and input from a multidisciplinary advisory panel. RESULTS: The pathway recommends formalized routine screening for anxiety and depression in patients with cancer at key points in the patient's journey. The Edmonton Symptom Assessment System or distress thermometer with problem checklist is recommended as brief screening tools, combined with a more detailed tool, such as the Hospital Anxiety and Depression Scale, to identify possible cases. A structured clinical interview will be required to confirm diagnosis. When anxiety or depression is identified, it is recommended that one person in a treating team takes responsibility for coordinating appropriate assessment, referral and follow-up (not necessarily carrying these out themselves). A stepped care model of intervention is proposed, beginning with the least intensive available that is still likely to provide significant health gain. The exact intervention, treatment length and follow-up timelines, as well as professionals involved, are provided as a guide only. Each service should identify their own referral network based on local resources and current service structure, as well as patient preference. DISCUSSION: This clinical pathway will assist cancer services to design their own systems to detect and manage anxiety and depression in their patients, to improve the quality of care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 2×
“A score of 11 or more suggests possible moderate to severe anxiety or depression [45].”
BackgroundMitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449
Andrews, G., Cuijpers, P., Craske, M. G., McEvoy, P., & Titov, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013196 · Cited by 1,311
Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age
Linden, W., Vodermaier, A., MacKenzie, R., & Greig, D. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.025 · Cited by 1,245 · cited 1×
“For instance, the Canadian study found that more than half of patients who were female and/or aged below 50 years presented with clinical or subclinical anxiety [5].”
BackgroundBower, P., & Gilbody, S. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.1.11 · Cited by 1,084 · cited 2×
“More intensive interventions are reserved for patients who do not benefit from simpler first-line treatments [53].”
BackgroundAndersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., Holland, J. C., Partridge, A. H., Bak, K., Somerfield, M. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4611 · Cited by 735
Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities
Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., Boehncke, A., Hund, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.0086 · Cited by 649
Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/eufn-rv1k-y3tr-fk0l · Cited by 621
Screening for Distress and Unmet Needs in Patients With Cancer: Review and Recommendations
Carlson, L. E., Waller, A., & Mitchell, A. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5509 · Cited by 550 · cited 1×
“[37], for depression, see Wakefield et al.”
Screening for emotional distress in cancer patients: a systematic review of assessment instruments
Vodermaier, A., Linden, W., & Siu, C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp336 · Cited by 541
Cited by
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Grassi, L., Caruso, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101155 · Cited by 316
Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis
Hashemi, S.-M., Rafiemanesh, H., Aghamohammadi, T., Badakhsh, M., Amirshahi, M., Sari, M., Behnamfar, N., & Roudini, K. (2020) · Breast Cancer · doi:10.1007/s12282-019-01031-9 · Cited by 243
Caruso, R., Nanni, M. G., Riba, M., Sabato, S., Mitchell, A. J., Croce, E., & Grassi, L. (2017) · Acta Oncologica · doi:10.1080/0284186x.2016.1266090 · Cited by 203
Murphy, M. J., Newby, J. M., Butow, P., Loughnan, S. A., Joubert, A. E., Kirsten, L., Allison, K., Shaw, J., Shepherd, H. L., Smith, J., et al. (2020) · Psycho-Oncology · doi:10.1002/pon.5267 · Cited by 93
Self-citationFear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?
Bergerot, C. D., Philip, E. J., Bergerot, P. G., Siddiq, N., Tinianov, S., & Lustberg, M. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100031 · Cited by 90
Metadata
- Authors
- Butow, P., Price, M. A., Shaw, J. M., Turner, J., Clayton, J. M., Grimison, P., Rankin, N., & Kirsten, L.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2015-08-13
- Volume
- 24
- Issue
- 9
- Pages
- 987-1001
- ISSN
- 1057-9249 (ISSN-L)
- OpenAlex
- W1946746919
- Cited by
- 213
- References
- 22
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines: Clinical pathway for anxiety and depression in cancer. https://app.cochat.ai/papers/10.1002/pon.3920
- The paper
- Butow, P., Price, M. A., Shaw, J. M., Turner, J., Clayton, J. M., Grimison, P., Rankin, N., & Kirsten, L. (2015). Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines: Clinical pathway for anxiety and depression in cancer. Psycho-Oncology. https://doi.org/10.1002/pon.3920
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.